Staley Capital Advisers Inc Vyne Therapeutics Inc. Transaction History
Staley Capital Advisers Inc
- $2.15 Billion
- Q1 2025
A detailed history of Staley Capital Advisers Inc transactions in Vyne Therapeutics Inc. stock. As of the latest transaction made, Staley Capital Advisers Inc holds 51,472 shares of VYNE stock, worth $18,529. This represents 0.0% of its overall portfolio holdings.
Number of Shares
51,472
Previous 36,472
41.13%
Holding current value
$18,529
Previous $117,000
30.77%
% of portfolio
0.0%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding VYNE
# of Institutions
3Shares Held
51.5KCall Options Held
0Put Options Held
0About VYNE Therapeutics Inc.
- Ticker VYNE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,005,600
- Market Cap $20.9M
- Description
- VYNE Therapeutics Inc., a pharmaceutical company, focuses on developing various therapeutics for the treatment of immuno-inflammatory conditions. The company develops FCD105, a topical combination foam that has completed Phase III clinical trials for the treatment of moderate-to-severe acne vulgaris; and FMX114, a combination of tofacitinib, whi...